Botanical species · safety record

Laportea aestuans

The EFSA Compendium of Botanicals holds 7 constituent measurements for Laportea aestuans. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Laportea aestuans (L.) Chew

7Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Saponins2
  • Alkaloids1
  • Diosgenin1
  • Methyl salicylate1
  • Myrcene1
  • Tannins1

Plant parts

  • Live plants4
  • Leaves3

Preparations

  • Solvent extraction6
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLive plantsSolvent extractionPhytochemical screeningResolve DOI
Methyl salicylateLive plantsEssential oil54.5 PercentGC-MSResolve DOI
SaponinsLive plantsSolvent extractionPhytochemical screeningResolve DOI
TanninsLive plantsSolvent extractionPhytochemical screeningResolve DOI
DiosgeninLeavesSolvent extraction3.199 Millilitre/100 gramGC-FIDNo resolvable identifier
MyrceneLeavesSolvent extraction13.608 Milligram/100 gramGC-FIDNo resolvable identifier
SaponinsLeavesSolvent extraction2.873 Milligram/100 gramGC-FIDNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Oloyede, G.K., Ayanbadejo, O.E. Phytochemical, toxicity, antimicrobial and antioxidant screening of extracts obtained from Laportea aestuans (Gaud). Journal of Medical Sciences (Faisalabad), 2014, vol. 14, no. 2, p. 51-59. DOI
  2. Oloyede, G.K. Toxicity, antimicrobial and antioxidant activities of methyl salicylate dominated essential oils of Laportea aestuans (Gaud). Arabian Journal of Chemistry, None. DOI
  3. Okereke, S. C., Elekwa, I., Nmaju, A. U. Gas chromatographic FID, hypoglycemic and hypolipidemic effects of leaves of Laportea aestuans in alloxan induced diabetes in male albino rats. IOSR Journal of Environmental Science, Toxicology and Food Technology, 2014, p. 42-46.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue